Table 2. Cell counts based on the expression of CD68 alone or together with CD80, CD86 or PD-L1.
The average counts ± S.D. are represented for each areas as indicated. The p values were calculated to assess the significance of differences between the HCV-infected and control group.
| Lobular | Portal | Total | |
|---|---|---|---|
| CD68+ count | |||
| HCV-infected patients | 36.3 ± 9.5 | 9.5 ± 5.5 | 45.8 ± 9.8 |
| Controls | 44 ± 12 | 10.9 ± 6 | 54.9 ± 13.8 |
| P value | 0.041 | 0.575 | 0.244 |
| CD68+CD80+ count | |||
| HCV-infected patients | 17.9 ± 14.2 | 5.3 ± 9.2 | 23.3 ± 20.3 |
| Controls | 7.6 ± 11.5 | 1.8 ± 2.8 | 9.3 ± 11.9 |
| P value | 0.002 | 0.332 | 0.015 |
| CD68+CD86+ count | |||
| HCV-infected patients | 7.5 ± 12.5 | 2.8 ± 6.9 | 10.2 ± 19.8 |
| Controls | 3.9 ± 3.9 | 1.6 ± 2.3 | 5.5 ± 5.7 |
| P value | 0.382 | 0.344 | 0.467 |
| CD68+PD-L1+ count | |||
| HCV-infected patients | 8.4 ± 9.1 | 1.4 ± 1.12 | 10.8 ± 9.8 |
| Controls | 2.5 ± 2 | 0.5 ± 0.8 | 2.9 ± 2.6 |
| P value | 0.07 | 0.058 | 0.028 |